BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35484798)

  • 1. "Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension." Catherine E. Simpson, Jenny Y. Chen, Rachel L. Damico,
    Eur Respir J; 2022 Apr; 59(4):. PubMed ID: 35484798
    [No Abstract]   [Full Text] [Related]  

  • 2. "Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension." Mark Toshner, Colin Church, Lars Harbaum,
    Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 35798371
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the Editor, regarding Li L, Zhu X, Chen X, Gao J, Ding C, et al. Advances in targeted therapy for pulmonary arterial hypertension in children. Eur J Pediatr. 2022 Dec 17.
    Beghetti M; Ivy D; Scott N; Machlitt-Northen S; Lukas MA
    Eur J Pediatr; 2023 May; 182(5):2453-2454. PubMed ID: 36847876
    [No Abstract]   [Full Text] [Related]  

  • 4. Correspondence, letter to the editor regarding Li L, Zhu X, Chen X, Gao J, Ding C, et al. Advances in targeted therapy for pulmonary arterial hypertension in children. Eur J Pediatr. 2022 Dec 17.
    Li L; Ning J; Ma S
    Eur J Pediatr; 2023 May; 182(5):2455. PubMed ID: 36847875
    [No Abstract]   [Full Text] [Related]  

  • 5. "Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms." S. Malenfant, M. Lebret, É. Breton-Gagnon,
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38355152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats." R. Dumitrascu, C. Kulcke, M. Königshoff,
    Eur Respir J; 2021 Dec; 58(6):. PubMed ID: 34916252
    [No Abstract]   [Full Text] [Related]  

  • 7. "Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice." Stephen Y. Chan and Lewis J. Rubin.
    Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29367412
    [No Abstract]   [Full Text] [Related]  

  • 8. "Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma." M.K. Ali, R.Y. Kim, A.C. Brown
    Eur Respir J; 2022 Sep; 60(3):. PubMed ID: 36175024
    [No Abstract]   [Full Text] [Related]  

  • 9. "Interstitial lung abnormalities are associated with decreased mean telomere length." R.K. Putman, G.T. Axelsson, S.Y. Ash,
    Eur Respir J; 2023 Sep; 62(3):. PubMed ID: 37690790
    [No Abstract]   [Full Text] [Related]  

  • 10. "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma." Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek,
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 35680153
    [No Abstract]   [Full Text] [Related]  

  • 11. "The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment." Silvia Ulrich and Ekkehard Grunig.
    Eur Respir J; 2021 Mar; 57(3):. PubMed ID: 33767003
    [No Abstract]   [Full Text] [Related]  

  • 12. "ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer." E.L. O'Dowd, I. Tietzova, E. Bartlett,
    Eur Respir J; 2024 Feb; 63(2):. PubMed ID: 38302184
    [No Abstract]   [Full Text] [Related]  

  • 13. "Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis." Nikhil Hirani, Alison C. MacKinnon, Lisa Nicol,
    Eur Respir J; 2022 Apr; 59(4):. PubMed ID: 35422427
    [No Abstract]   [Full Text] [Related]  

  • 14. "Age-related changes in plasma biomarkers and their association with mortality in COVID-19." E.H.A. Michels, B. Appelman, J. de Brabander,
    Eur Respir J; 2024 Feb; 63(2):. PubMed ID: 38423593
    [No Abstract]   [Full Text] [Related]  

  • 15. "Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update." S. Ghosh, L. Breitscheidel, N. Lazarevic,
    Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 38237996
    [No Abstract]   [Full Text] [Related]  

  • 16. Progression and prognostic indicators of bronchial disease in children with sickle cell disease.
    Williams SN; Nussbaum E; Yoonessi L; Morphew T; Randhawa I
    Lung; 2014 Jun; 192(3):385-93. PubMed ID: 24699774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline." James D. Chalmers, Megan L. Crichton, Pieter C. Goeminne,
    Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35948349
    [No Abstract]   [Full Text] [Related]  

  • 18. "Spatial transcriptomics for respiratory research and medicine." S. Curras-Alonso, J. Soulier, T. Walter,
    Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36822638
    [No Abstract]   [Full Text] [Related]  

  • 19. "Normative data for multiple breath washout outcomes in school-aged Caucasian children." Pinelopi Anagnostopoulou, Philipp Latzin, Renee Jensen,
    Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35981729
    [No Abstract]   [Full Text] [Related]  

  • 20. "Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease." Laurent Savale, Anoosha Habibi, François Lionnet, Bernard Maitre, Vincent Cottin, Xavier Jais, Ari Chaouat, Elise Artaud-Macari, Matthieu Canuet, Grégoire Prevot, Christelle Chantalat-Auger, David Montani, Olivier Sitbon, Fréderic Galacteros, Gérald Simonneau, Florence Parent, Pablo Bartolucci and Marc Humbert.
    Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 32001502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.